Effect of micronutrient supplementation on disease progression in asymptomatic, antiretroviral-naive, HIV-infected adults in Botswana: A randomized clinical trial

JAMA

Volumn 310, Issue 20, 2013, Pages 2154-2163

  Baum, Marianna K ^a   Campa, Adriana ^a   Lai, Shenghan ^e   Sales Martinez, Sabrina ^a   Tsalaile, Lesedi ^b   Burns, Patricia ^c   Farahani, Mansour ^c   Li, Yinghui ^a   Van Widenfelt, Erik ^b   Page, John Bryan ^d   Bussmann, Hermann ^b   Fawzi, Wafaie W ^c   Moyo, Sikhulele ^b   Makhema, Joseph ^b   Thior, Ibou ^b   Essex, Myron ^c   Marlink, Richard ^c  

^a FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^b BOTSWANA HARVARD AIDS INSTITUTE PARTNERSHIP   (Botswana)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF MIAMI   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIRETROVIRUS AGENT; ASCORBIC ACID; CD4 ANTIGEN; CYANOCOBALAMIN; FOLIC ACID; MULTIVITAMIN; NICOTINIC ACID; PLACEBO; PYRIDOXINE; RIBOFLAVIN; SELENIUM; THIAMINE; TRACE ELEMENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; ASYMPTOMATIC INFECTION; BOTSWANA; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DEATH; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; FACTORIAL DESIGN; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MORBIDITY; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; VIRUS LOAD; VITAMIN SUPPLEMENTATION;

EID: 84888623108     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2013.280923     Document Type: Article

References (41)

1. Prevalence of HIV, total (% of population ages 15-49). World Bank. http://data.worldbank.org/indicator/SH.DYN.AIDS.ZS. Accessed October 17, 2013.
2. Sullivan PS, Fideli U, Wall KM, et al. Prevalence of seroconversion symptoms and relationship to set-point viral load: findings from a subtype C epidemic, 1995-2009. AIDS. 2012;26(2):175-184.
3. Mlotshwa M, Riou C, Chopera D, et al; CAPRISA 002 Study Team. Fluidity of HIV-1-specific T-cell responses during acute and early subtype C HIV-1 infection and associations with early disease progression. J Virol. 2010;84(22):12018-12029.
4. Bussmann H, Wester CW, Thomas A, et al. Response to zidovudine/ didanosine-containing combination antiretroviral therapy among HIV-1 subtype C-infected adults in Botswana: two-year outcomes from a randomized clinical trial. J Acquir Immune Defic Syndr. 2009;51(1):37-46.
5. WHO issues new HIV recommendations calling for earlier treatment. World Health Organization news release. http://www.who.int/mediacentre/news/releases/ 2013/new-hiv-recommendations-20130630/en/index.html. Accessed July 3, 2013.
6. De Cock KM, El-Sadr WM. When to start ART in Africa: an urgent research priority. N Engl J Med. 2013;368(10):886-889. doi:10.1056/NEJMp1300458.
7. Carter GM, Elion R, Kuebel M, et al. Supplementing antiretroviral therapy. Science. 2002;297(5585):1276.
8. Beach RS, Mantero-Atienza E, Shor-Posner G, et al. Specific nutrient abnormalities in asymptomatic HIV-1 infection. AIDS. 1992;6(7):701-708.
9. Baum MK, Shor-Posner G, Lu Y, et al. Micronutrients and HIV-1 disease progression. AIDS. 1995;9(9):1051-1056.
10. Jiamton S, Pepin J, Suttent R, et al. A randomized trial of the impact of multiple micronutrient supplementation on mortality among HIV-infected individuals living in Bangkok. AIDS. 2003;17(17):2461-2469.
11. Kaiser JD, Campa AM, Ondercin JP, Leoung GS, Pless RF, Baum MK. Micronutrient supplementation increases CD4 count in HIV-infected individuals on highly active antiretroviral therapy: a prospective, double-blinded, placebo-controlled trial. J Acquir Immune Defic Syndr. 2006;42(5):523-528.
12. Range N, Changalucha J, Krarup H, Magnussen P, Andersen AB, Friis H. The effect of multi-vitamin/mineral supplementation on mortality during treatment of pulmonary tuberculosis: a randomised two-by-two factorial trial in Mwanza, Tanzania. Br J Nutr. 2006;95(4):762-770.
13. Fawzi WW, Msamanga GI, Spiegelman D, et al. A randomized trial of multivitamin supplements and HIV disease progression and mortality. N Engl J Med. 2004;351(1):23-32.
14. Beisel WR. AIDS. In: Gershwin ME, German JB, Keen CL, eds. Nutrition and Immunology: Principles and Practices. Totowa, NJ: Humana Press; 2000:389-403.
15. Hurwitz BE, Klaus JR, Llabre MM, et al. Suppression of human immunodeficiency virus type 1 viral load with selenium supplementation: a randomized controlled trial. Arch Intern Med. 2007;167(2):148-154.
16. Baum MK. Role of micronutrients in HIV-infected intravenous drug users. J Acquir Immune Defic Syndr. 2000;25(suppl 1):S49-S52.
17. Mazhani L. Handbook of the 2008 Botswana National HIV/AIDS Guidelines. Botswana Health Services, Dept of HIV/AIDS Prevention and Care; 2008.
18. Self SG, Mauritsen R. Power/sample size calculations for generalized linear models. Biometrics. 1988;44:79-86.
19. Self SG, Mauritsen R, Oghara J. Power calculations for likelihood ratio tests in generalized linear models. Biometrics. 1992;48:31-39.
20. Schoenfeld DA. Issues in the testing of drug combination. In: Finkelstein DM, Schoenfeld DA, eds. AIDS Clinical Trials. Hoboken, NJ: Wiley & Sons; 1995.
21. Schoenfeld D. Partial residuals for the proportional hazards regression model. Biometrika. 1982;69(1):239-241.
22. Hughes MD, Pocock SJ. Interim monitoring of clinical trials. In: Finkelstein DM, Schoenfeld DA, eds. AIDS Clinical Trials. Hoboken, NJ: Wiley & Sons; 1995:177-196.
23. Safety reporting requirements for human drug and biological products: proposed rule: part II. 21 CFR Parts 310, 312, et al [March 2003]. Food and Drug Administration. Dept of Health and Human Services; 2003.
24. Piot P, Quinn TC. Response to the AIDS pandemic: a global health model. N Engl J Med. 2013;368(23):2210-2218.
25. Cohen MS, Chen YQ, McCauley M, et al; HPTN 052 Study Team. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493-505.
26. Villamor E, Mugusi F, Urassa W, et al. A trial of the effect of micronutrient supplementation on treatment outcome, T cell counts, morbidity, and mortality in adults with pulmonary tuberculosis. J Infect Dis. 2008;197(11):1499-1505.
27. Kelly P, Katubulushi M, Todd J, et al. Micronutrient supplementation has limited effects on intestinal infectious disease and mortality in a Zambian population of mixed HIV status: a cluster randomized trial. Am J Clin Nutr. 2008;88(4):1010-1017.
28. McClelland RS, Baeten JM, Overbaugh J, et al. Micronutrient supplementation increases genital tract shedding of HIV-1 in women: results of a randomized trial. J Acquir Immune Defic Syndr. 2004;37(5):1657-1663.
29. Baum M, Campa A, Lai S, et al. Micronutrient supplementation to prevent disease progression in HIV infected adults in Botswana. Poster presented at: XVIII International HIV/AIDS Conference; July 18-23, 2010; Vienna, Austria.
30. Robson LC, Schwartz RM, Perkins WD. The effects of vitamin B6 deficiency on the lymphoid system and immune responses. In: Tryfiates CP, ed. Vitamin B6 Metabolism and Role in Growth. Westport, CT: Food and Nutrition Press; 1980:205-222.
31. Lee J, Yoshikawa K, Watson RR. Nutritional deficiencies in AIDS patients: a treatment opportunity. In: Standish LJ, Galantino ML, Calabrese C, eds. AIDS and Complementary and Alternative Medicine. London, UK: Churchill Livingstone; 1999:56-70.
32. Gross RL, Reid JV, Newberne PM, Burgess B, Marston R, Hift W. Depressed cell-mediated immunity in megaloblastic anemia due to folic acid deficiency. Am J Clin Nutr. 1975;28(3):225-232.
33. Jacob RA, Kelley DS, Pianalto FS, et al. Immunocompetence and oxidant defense during ascorbate depletion of healthy men. Am J Clin Nutr. 1991;54(6)(suppl):1302S-1309S.
34. Hemila H. Vitamin C and infectious diseases. In: Pacler L, Fuchs J, eds. Vitamin C in Health and Disease. New York, NY: Marcel Dekker; 1997.
35. Tengerdy RP. The role of vitamin E in immune response and disease resistance. Ann N Y Acad Sci. 1990;587:24-33.
36. Wang Y, Huang DS, Liang B, Watson RR. Nutritional status and immune responses inmice with murine AIDS are normalized by vitamin E supplementation. J Nutr. 1994;124(10):2024-2032.
37. Beisel WR. Single nutrients and immunity. Am J Clin Nutr. 1982;35(2)(suppl):417-468.
38. Zhao L, Cox AG, Ruzicka JA, Bhat AA, Zhang W, Taylor EW. Molecular modeling and in vitro activity of an HIV-1-encoded glutathione peroxidase. Proc Natl Acad Sci U S A. 2000;97(12):6356-6361.
39. Stone CA, Kawai K, Kupka R, Fawzi WW. Role of selenium in HIV infection. Nutr Rev. 2010;68(11):671-681.
40. Spallholz JE, Boylan LM, Larsen HS. Advances in understanding selenium's role in the immune system. Ann N Y Acad Sci. 1990;587:123-139.
41. Peretz A, Nève J, Desmedt J, Duchateau J, Dramaix M, Famaey J-P. Lymphocyte response is enhanced by supplementation of elderly subjects with selenium-enriched yeast. Am J Clin Nutr. 1991;53(5):1323-1328.